Why people use BPC-157 for plantar fasciitis
Heel pain that won't go away with rest, ice, stretches. BPC-157? The honest answer: it is mixed - some real signal, a lot of anecdote. Popular among runners and people on their feet all day.
This page covers what's known, what's not, and what the editorial take is for normal humans considering BPC-157 for plantar fasciitis.
What the evidence says
Evidence tier: Moderate anecdotal. Strong real-world anecdotal track record; mechanism extrapolates from related research.
- Popular among runners and people on their feet all day.
- Mechanism overlaps with general fascial repair, though no specific plantar fascia studies exist.
- Most users pair with proper footwear correction and stretching protocol.
Protocol notes
Subcutaneous injection in foot or systemic. 250mcg/day for 4-6 weeks.
Always with a sports-medicine doctor, telehealth provider, or specialist sign-off. Self-experimenting on injection schedules without clinical input is the most common way people waste money and get hurt.
What to skip
- Vendors without a Certificate of Analysis (COA). Random gym-bro vendors with no third-party testing. The peptide market has a quality-control problem; the answer is COA per peptide, every time.
- Pre-mixed blends from non-pharmacy sources. Compounding pharmacies that produce pre-mixed combinations with COAs are fine. Random vendor "stack vials" are not.
- Massively over-dosed protocols. More is rarely better with peptides. Receptor saturation is real. Stick to evidence-based dosing.
Where to go next
- Full BPC-157 directory entry - status, sourcing, studies, what to skip
- What are peptides - if you skipped the foundation
- How peptides actually work - mechanism in plain English
- The Tier List - which ones to take seriously
- Subscribe to the dispatch